Nitric oxide synthase expression and nitric oxide toxicity in oligodendrocytes

Antioxidants and Redox Signaling

Volumn 8, Issue 5-6, 2006, Pages 967-980

  Boullerne, Anne I ^a   Benjamins, Joyce A ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CALCIUM; CYTOKINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTAMIC ACID; GLUTATHIONE; INDUCIBLE NITRIC OXIDE SYNTHASE; MYELIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

CELL ACTIVATION; CELL CULTURE; CELL DAMAGE; CELL INTERACTION; CELL LEVEL; CYTOTOXICITY; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENE INDUCTION; HUMAN; IN VIVO STUDY; MICROGLIA; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW;

ANIMALS; CALCIUM; CELL DEATH; CELLS, CULTURED; HUMANS; ISOENZYMES; MITOCHONDRIA; NEURONS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OLIGODENDROGLIA;

EID: 33745840525     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2006.8.967     Document Type: Review

References (108)

1. Bagasra O, Michaels FH, Zheng YM, Bobroski LE, Spitsin SV, Fu ZF, Tawadros R, and Koprowski H. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc Natl Acad Sci USA 92: 12041-12045, 1995.
2. Bal-Price A, Moneer Z, and Brown GC. Nitric oxide induces rapid, calcium-dependent release of vesicular glutamate and ATP from cultured rat astrocytes. Glia 40: 312-323, 2002.
3. Baltrons MA and Garcia A. AMPA receptors are coupled to the nitric oxide/cyclic GMP pathway in cerebellar astroglial cells. Eur J Neurosci 9: 2497-2501, 1997.
4. Baltrons MA and Garcia A. The nitric oxide/cyclic GMP system in astroglial cells. Prog Brain Res 132: 325-337, 2001.
5. Barna M, Komatsu T, and Reiss CS. Activation of type III nitric oxide synthase in astrocytes following a neurotropic viral infection. Virology 223: 331-343, 1996.
6. Baud O, Li J, Zhang Y, Neve RL, Volpe JJ, and Rosenberg PA. Nitric oxide-induced cell death in developing oligodendrocytes is associated with mitochondrial dysfunction and apoptosis-inducing factor translocation. Eur J Neurosci 20: 1713-1726, 2004.
7. Benjamins JA and Nedelkoska L. Protection of mature oligodendrocytes: cross talk between cyclic GMP and growth factors. J Neurochem 85 (Suppl. 1): 37, 2003. (Abstract)
8. Benjamins JA and Nedelkoska N. Metabotropic glutamate receptors 1 and 5 activate protein kinase G to protect against kainate excitotoxicity in oligodendrocyte. J Neurochem 94 (Suppl. 1): 107, 2005. (Abstract)
9. Bhat NR, Zhang P, and Bhat AN. Cytokine induction of inducible nitric oxide synthase in an oligodendrocyte cell line: role of p38 mitogen-activated protein kinase activation. J Neurochem 72: 472-478, 1999.
10. Bizzozero OA, DeJesus G, and Howard TA. Exposure of rat optic nerves to nitric oxide causes protein 5-nitrosation and myelin decompaction. Neurochem Res 29: 1675-1685, 2004.
11. Boullerne AI, Nedelkoska L, and Benjamins JA. Synergism of nitric oxide and iron in killing the transformed murine oligodendrocyte cell line N20.1. J Neurochem 72: 1050-1060, 1999.
12. Boullerne AI, Nedelkoska L, and Benjamins JA. Role of calcium in nitric oxide-induced cytotoxicity: EGTA protects mouse oligodendrocytes. J Neurosci Res 63: 124-135, 2001.
13. th International Symposium of Neuron-Glia Interactions, June 20-22, 2005. Montreal, Canada. (Abstract)
14. Broholm H, Braendstrup O, and Lauritzen M. Nitric oxide synthase expression of oligodendrogliomas. Clin Neuropathol 20: 233-238, 2001.
15. Broholm H, Andersen B, Wanscher B, Frederiksen JL, Rubin I, Pakkenberg B, Larsson HB, and Lauritzen M. Nitric oxide synthase expression and enzymatic activity in multiple sclerosis. Acta Neurol Scand 109: 261-269, 2004.
16. Brosnan CF, Battistini L, Raine CS, Dickson DW, Casadevall A, and Lee SC. Reactive nitrogen intermediates in human neuropathology: an overview. Dev Neurosci 16: 152-161, 1994.
17. Brundin L, Morcos E, Olsson T, Wiklund NP, and Andersson M. Increased intrathecal nitric oxide formation in multiple sclerosis; cerebrospinal fluid nitrite as activity marker. Eur J Neurol 6: 585-590, 1999.
18. Buskila Y, Farkash S, Hershfinkel M, and Amitai Y. Rapid and reactive nitric oxide production by astrocytes in mouse neocortical slices. Glia 52: 169-176, 2005.
19. Calabrese V, Raffaele R, Cosentino E, and Rizza V Changes in cerebrospinal fluid levels of malondialdehyde and glutathione reductase activity in multiple sclerosis. Int J Clin Pharmacol Res 14: 119-123, 1994.
20. Calabrese V, Scapagnini G, Ravagna A, Bella R, Foresti R, Bates TE, Giuffrida Stella AM, and Pennisi G. Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels. J Neurosci Res 70: 580-587, 2002.
21. Cande C, Vahsen N, Metivier D, Tourriere H, Chebli K, Garrido C, Tazi J, and Kroemer G. Regulation of cytoplasmic stress granules by apoptosis-inducing factor. J Cell Sci 117: 4461-4468, 2004.
22. Chang A, Tourtellotte WW, Rudick R, and Trapp BD. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 346: 165-173, 2002.
23. Clement P, Sarda N, Cespuglio R, and Gharib A. Changes occurring in cortical NO release and brain NO-synthases during a paradoxical sleep deprivation and subsequent recovery in the rat. J Neurochem 90: 848-856, 2004.
24. Clementi E, Brown GC, Feelisch M, and Moncada S. Persistent inhibition of cell respiration by nitric oxide: crucial role of 5-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc Natl Acad Sci USA 95: 7631-7636, 1998.
25. Cross AH, Manning PT, Keeling RM, Schmidt RE, and Misko TP. Peroxynitrite formation within the central nervous system in active multiple sclerosis. J Neuroimmunol 88: 45-56, 1998.
26. Daniiov AI, Andersson M, Bavand N, Wiklund NP, Olsson T, and Brundin L. Nitric oxide metabolite determinations reveal continuous inflammation in multiple sclerosis. J Neuroimmunol 136: 112-118, 2003.
27. De Los Monteros AE, Zhao PM, and De Vellis J. In vitro injury model for oligodendrocytes: development, injury, and recovery. Microsc Res Tech 52: 719-730, 2001.
28. Dello Russo C, Boullerne AI, Gavrilyuk V, and Feinstein DL. Inhibition of microglial inflammatory responses by norepinephrine: effects on nitric oxide and interleukin-1beta production. J Neuroinflam 1: 9, 2004.
29. Demas GE, Kriegsfeld LJ, Blackshaw S, Huang P, Gammie SC, Nelson RJ, and Snyder SH. Elimination of aggressive behavior in male mice lacking endothelial nitric oxide synthase. J Neurosci 19: RC30, 1999.
30. Deng W, Wang H, Rosenberg PA, Volpe JJ, and Jensen FE. Role of metabotropic glutamate receptors in oligodendrocyte excitotoxicity and oxidative stress. Proc Natl Acad Sci USA 101: 7751-7756, 2004.
31. Druzhyna NM, Musiyenko SI, Wilson GL, and LeDoux SP. Cytokines induce nitric oxide-mediated mtDNA damage and apoptosis in oligodendrocytes. Protective role of targeting 8-oxoguanine glycosylase to mitochondria. J Biol Chem 280: 21673-21679, 2005.
32. Fragoso G, Martinez-Bermudez AK, Liu HN, Khorchid A, Chemtob S, Mushynski WE, and Almazan G. Developmental differences in HO-induced oligodendrocyte cell death: role of glutathione, mitogen-activated protein kinases and caspase 3. J Neurochem 90: 392-404, 2004.
33. Fujii H, Wan X, Zhong J, Berliner LJ, and Yoshikawa K. In vivo imaging of spin-trapped nitric oxide in rats with septic shock: MRI spin trapping. Magn Reson Med 42: 235-239, 1999.
34. Fujii H and Berliner LJ. Ex vivo EPR detection of nitric oxide in brain tissue. Magn Reson Med 42: 599-602, 1999.
35. Gabbott PL and Bacon SJ. Localisation of NADPH diaphorase activity and NOS immunoreactivity in astroglia in normal adult rat brain. Brain Res 714: 135-144, 1996.
36. Gahm C, Holmin S, and Mathiesen T. Nitric oxide synthase expression after human brain contusion. Neurosurgery 50: 1319-1326, 2002.
37. Garthwaite G, Batchelor AM, Goodwin DA, Hewson AK, Leeming K, Ahmed Z, Cuzner ML, and Garthwaite J. Pathological implications of iNOS expression in central white matter: an ex vivo study of optic nerves from rats with experimental allergic encephalomyelitis. Eur J Neurosci 21: 2127-2135, 2005.
38. Gegg ME, Beltran B, Salas-Pino S, Bolanos JP, Clark JB, Moncada S, and Heales SJ. Differential effect of nitric oxide on glutathione metabolism and mitochondrial function in astrocytes and neurones: implications for neuroprotection/neurodegeneration? J Neurochem 86: 228-237, 2003.
39. Gene S, Gene K, Kumral A, Baskin H, and Ozkan H. Bilirubin is cytotoxic to rat oligodendrocytes in vitro. Brain Res 985: 135-141, 2003.
40. Ghafourifar P, Bringold U, Klein SD, and Richter C. Mitochondrial nitric oxide synthase, oxidative stress and apoptosis. Biol Signals Recept 10: 57-65, 2001.
41. Ghafourifar P and Cadenas E. Mitochondrial nitric oxide synthase. Trends Pharmacol Sci 26: 190-195, 2005.
42. Gold R, Zielasek J, Kiefer R, Toyka KV, and Hartung HP. Secretion of nitrite by Schwann cells and its effect on T-cell activation in vitro. Cell Immunol 168: 69-77, 1996.
43. Hashiguchi A, Yano S, Morioka M, Hamada J, Ushio Y, Takeuchi Y, and Fukunaga K. Up-regulation of endothelial nitric oxide synthase via phosphatidylinositol 3-kinase pathway contributes to ischemic tolerance in the CA1 subfield of gerbil hippocampus. J Cereb Blood Flow Metab 24: 271-279, 2004.
44. Haynes RL, Folkerth RD, Keefe RJ, Sung I, Swzeda LI, Rosenberg PA, Volpe JJ, and Kinney HC, Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. J Neuropathol Exp Neurol 62: 441-450, 2003.
45. Heneka MT and Feinstein DL. Expression and function of inducible nitric oxide synthase in neurons. J Neuroimmunol 114: 8-18, 2001.
46. Hewett JA, Hewett SJ, Winkler S, and Pfeiffer SE. Inducible nitric oxide synthase expression in cultures enriched for mature oligodendrocytes is due to microglia. J Neurosci Res 56: 189-198, 1999.
47. Hill KE, Zollinger LY Watt HE, Carlson NG, and Rose JW Inducible nitric oxide synthase in chronic active multiple sclerosis plaques: distribution, cellular expression and association with myelin damage. J Neuroimmunol 151: 171-179, 2004.
48. Hooper DC, Ohnishi ST, Kean R, Numagami Y, Dietzschold B, and Koprowski H. Local nitric oxide production in viral and autoimmune diseases of the central nervous system. Proc Natl Acad Sci USA 92: 5312-5316, 1995.
49. Hu J, Ferreira A, and Van Eldik LJ. S100beta induces neuronal cell death through nitric oxide release from astrocytes. J Neurochem 69: 2294-2301, 1997.
50. Huang PL. Neuronal and endothelial nitric oxide synthase gene knockout mice. Braz J Med Biol Res 32: 1353-1359, 1999.
51. Itoh K, Watanabe M, Yoshikawa K, Kanaho Y, Berliner LJ, and Fujii H. Magnetic resonance and biochemical studies during pentylenetetrazole-kindling development: the relationship between nitric oxide, neuronal nitric oxide synthase and seizures. Neuroscience 129: 757-766, 2004.
52. Iwase K, Miyanaka K, Shimizu A, Nagasaki A, Gotoh T, Mori M, and Takiguchi M. Induction of endothelial nitric-oxide synthase in rat brain astrocytes by systemic lipopolysaccharide treatment. J Biol Chem 275: 11929-11933, 2000.
53. Juurlink BH, Thorburne SK, and Hertz L. Peroxide-scavenging deficit underlies oligodendrocyte susceptibility to oxidative stress. Glia 22: 371-378, 1998.
54. Kaneko K, Itoh K, Berliner LJ, Miyasaka K, and Fujii H. Consequences of nitric oxide generation in epileptic-seizure rodent models as studied by in vivo EPR. Magn Reson Med 48: 1051-1056, 2002.
55. Kang YC, Kim PK, Choi BM, Chung HT, Ha KS, Kwon YG, and Kim YM. Regulation of programmed cell death in neuronal cells by nitric oxide. In Vivo 18: 367-376, 2004.
56. 55a. Karadottir R, Cavelier P, Bergersen LH, and Attwell D. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 438: 1162-1166, 2005.
57. Keilhoff G, Seidel B, and Wolf G. Absence of nitric oxide synthase in rat oligodendrocytes: a light and electron microscopic study. Acta Histochem 100: 409-417, 1998.
58. Keynes RG, Griffiths C, and Garthwaite J. Superoxide-dependent consumption of nitric oxide in biological media may confound in vitro experiments. Biochem J 369: 399-406, 2003.
59. Keynes RG, Duport S, and Garthwaite J. Hippocampal neurons in organotypic slice culture are highly resistant to damage by endogenous and exogenous nitric oxide. Eur J Neurosci 19: 1163-1173, 2004.
60. Kim PK, Kwon YG, Chung HT, and Kim YM. Regulation of caspases by nitric oxide. Ann NY Acad Sci 962: 42-52, 2002.
61. Lee Y and Shin T. Expression of constitutive endothelial and inducible nitric oxide synthase in the sciatic nerve of Lewis rats with experimental autoimmune neuritis. J Neuroimmunol 126: 78-85, 2002.
62. Lee JT, Xu J, Lee JM, Ku G, Han X, Yang DI, Chen S, and Hsu CY. Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway. J Cell Biol 164: 123-131, 2004.
63. Lees RD, Slater P, and D'Souza SW. Nitric oxide does not modulate kainate receptor binding in human brain. Neurosci Lett 233: 133-136, 1997.
64. 62a. Li J, Band O, Vartanian T, Volpe JJ, and Rosenberg PA. Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. Proc Natl Acad Sci USA 102: 9936-9941, 2005.
65. Liu JS, Zhao ML, Brosnan CF, and Lee SC. Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. Am J Pathol 158: 2057-2066, 2001.
66. Luyt K, Varadi A, and Molnar E. Functional metabotropic glutamate receptors are expressed in oligodendrocyte progenitor cells. J Neurochem 84: 1452-1464, 2003.
67. Luyt K, Varadi A, Halfpenny CA, Scolding NJ, and Molnar E. Metabotropic glutamate receptors are expressed in adult human glial progenitor cells. Biochem Biophys Res Commun 319: 120-129, 2004.
68. Mackenzie-Graham AJ, Mitrovic B, Smoll A, and Merrill JE. Differential sensitivity to nitric oxide in immortalized, cloned murine oligodendrocyte cell lines. Dev Neurosci 16: 162-171, 1994.
69. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie QW, Sokol K, Hutchinson N, et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81: 641-650, 1995.
70. Malinski T, Bailey F, Zhang ZG, and Chopp M. Nitric oxide measured by a porphyrinic microsensor in rat brain after transient middle cerebral artery occlusion. J Cereb Blood Flow Metab 13: 355-358, 1993.
71. Martinez-Palma L, Pehar M, Cassina P, Peluffo H, Castellanos R, Anesetti G, Beckman JS, and Barbeito L. Involvement of nitric oxide on kainate-induced toxicity in oligodendrocyte precursors. Neurotox Res 5: 399-406, 2003.
72. Merrill JE, Ignarro LJ, Sherman MP, Melinek J, and Lane TE. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 151: 2132-2141, 1993.
73. Merrill JE, Murphy SP, Mitrovic B, Mackenzie-Graham A, Dopp JC, Ding M, Griscavage J, Ignarro LJ, and Lowenstein CJ. Inducible nitric oxide synthase and nitric oxide production by oligodendrocytes. J Neurosci Res 48: 372-384, 1997.
74. 71a. Micu I, Jiang Q, Coderre E, Ridsdale A, Zhang L, Woulfe J, Yin X, Trapp BD, McRory JE, Rehak R, Zamponi GW, Wang W, and Stys PK. NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia. Nature 439: 988-992, 2006.
75. Miller G. Neuroscience. The dark side of glia. Science 308: 778-781, 2005.
76. Mitrovic B, Ignarro LJ, Montestruque S, Smoll A, and Merrill JE. Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro. Neuroscience 61: 575-585, 1994.
77. Mitrovic B, Ignarro LJ, Vinters HV, Akers MA, Schmid I, Uittenbogaart C, and Merrill JE. Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes. Neuroscience 65: 531-539, 1995.
78. Molina-Holgado E, Vela JM, Arevalo-Martin A, and Guaza C. LPS/IFN-gamma cytotoxicity in oligodendroglial cells: role of nitric oxide and protection by the anti-inflammatory cytokine IL-10. Eur J Neurosci 13: 493-502, 2001.
79. Nelson EJ, Connolly J, and McArthur P. Nitric oxide and S-nitrosylation: excitotoxic and cell signaling mechanism. Biol Cell 95: 3-8, 2003.
80. Newcombe J, Li H, and Cuzner ML. Low density lipoprotein uptake by macrophages in multiple sclerosis plaques: implications for pathogenesis. Neuropathol Appl Neurobiol 20: 152-162, 1994.
81. Oleszak EL, Zaczynska E, Bhattacharjee M, Butunoi C, Legido A, and Katsetos CD. Inducible nitric oxide synthase and nitrotyrosine are found in monocytes/macrophages and/or astrocytes in acute, but not in chronic, multiple sclerosis. Clin Diag Lab Immunol 5: 438-445, 1998.
82. Ortiz PA and Garvin JL. Trafficking and activation of eNOS in epithelial cells. Acta Physiol Scand 179: 107-114, 2003.
83. Paez PM, Garcia CI, Davio C, Campagnoni AT, Soto EF, and Pasquini JM. Apotransferrin promotes the differentiation of two oligodendroglial cell lines. Glia 46: 207-217, 2004.
84. Pahan K, Sheikh FG, Namboodiri AM, and Singh I. Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J Clin Invest 100: 2671-2679, 1997.
85. Perez-Capote K, Serratosa J, and Sola C. Glial activation modulates glutamate neurotoxicity in cerebellar granule cell cultures. Glia 45: 258-268, 2004.
86. Perez SE, Adrio F, Rodriguez MA, Rodriguez-Moldes I, and Anadon R. NADPH-diaphorase histochemistry reveals oligodendrocytes in the rainbow trout (teleosts). Neurosci Lett 205: 83-86, 1996.
87. Pitt D, Nagelmeier IE, Wilson HC, and Raine CS. Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis. Neurology 61: 1113-1120, 2003.
88. Qi X and Guy J. Localization of NADPH diaphorase/nitric oxide synthase in the optic nerve of the normal guinea pig: a light and electron microscopic study. J Comp Neurol 370: 396-404, 1996.
89. Reif A, Schmitt A, Fritzen S, Chourbaji S, Bartsch C, Urani A, Wycislo M, Mossner R, Sommer C, Gass P, and Lesch KP. Differential effect of endothelial nitric oxide synthase (NOS-III) on the regulation of adult neurogenesis and behaviour. Eur J Neurosci 20: 885-895, 2004.
90. Rosenberg PA, Li Y, Ali S, Altiok N, Back SA, and Volpe JJ. Intracellular redox state determines whether nitric oxide is toxic or protective to rat oligodendrocytes in culture. J Neurochem 73: 476-484, 1999.
91. 87a. Salter MG and Fern R. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature 438: 1167-1171, 2005.
92. Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE, Sherman PA, Sessa WC, and Smithies O. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci USA 93: 13176-13181, 1996.
93. Sjakste N, Sjakste J, Boucher JL, Baumane L, Sjakste T, Dzintare M, Meirena D, Sharipova J, and Kalvinsh I. Putative role of nitric oxide synthase isoforms in the changes of nitric oxide concentration in rat brain cortex and cerebellum following sevoflurane and isoflurane anaesthesia. Eur J Pharmacol 513: 193-205, 2005.
94. 2+ signals in oligodendrocyte progenitors. Cell Calcium 26: 121-130, 1999.
95. Smith KJ, Kapoor R, and Felts PA. Demyelination: the role of reactive oxygen and nitrogen species. Brain Pathol 9: 69-92, 1999.
96. Stasiolek M, Gavrilyuk V, Sharp A, Horvath P, Selmaj K, and Feinstein DL. Inhibitory and stimulatory effects of lactacystin on expression of nitric oxide synthase type 2 in brain glial cells. The role of Ikappa B-beta. J Biol Chem 275: 24847-24856, 2000.
97. Svenningsson A, Petersson AS, Andersen O, and Hansson GK. Nitric oxide metabolites in CSF of patients with MS are related to clinical disease course. Neurology 53: 1880-1882, 1999.
98. Swanson RA, Ying W, and Kauppinen TM. Astrocyte influences on ischemic neuronal death. Curr Mol Med 4: 193-205, 2004.
99. Takahashi JL, Giuliani F, Power C, Imai Y, and Yong VW. Interleukin-1beta promotes oligodendrocyte death through glutamate excitotoxicity. Ann Neurol 53: 588-595, 2003.
100. Touil T, Deloire-Grassin MS, Vital C, Petry KG, and Brochet B. In vivo damage of CNS myelin and axons induced by peroxynitrite. Neuroreport 12: 3637-3644, 2001.
101. Van der Veen RC and Roberts LJ. Contrasting roles for nitric oxide and peroxynitrite in the peroxidation of myelin lipids. J Neuroimmunol 95: 1-7, 1999.
102. Wiencken AE and Casagrande VA. Endothelial nitric oxide synthetase (eNOS) in astrocytes: another source of nitric oxide in neocortex. Glia 26: 280-290, 1999.
103. Wosik K, Ruffini F, Almazan G, Olivier A, Nalbantoglu J, and Antel JP. Resistance of human adult oligodendrocytes to AMPA/kainate receptor-mediated glutamate injury. Brain 127: 2636-2648, 2004.
104. Ye ZC and Sontheimer H. Glial glutamate transport as target for nitric oxide: consequences for neurotoxicity. Prog Brain Res 118: 241-251, 1998.
105. Yoshioka A, Yamaya Y, Saiki S, Kanemoto M, Hirose G, and Pleasure D. Cyclic GMP/cyclic GMP-dependent protein kinase system prevents excitotoxicity in an immortalized oligodendroglial cell line. J Neurochem 74: 633-640, 2000.
106. Yung HW, Bal-Price AK, Brown GC, and Tolkovsky AM. Nitric oxide-induced cell death of cerebrocortical murine astrocytes is mediated through p53- and Bax-dependent pathways. J Neurochem 89: 812-821, 2004.
107. Zeng C, Lee JT, Chen H, Chen S, Hsu CY, and Xu J. Amyloid-beta peptide enhances tumor necrosis factor-alpha-induced iNOS through neutral sphingomyelinase/ceramide pathway in oligodendrocytes. J Neurochem 94: 703-712, 2005.
108. Ziak D, Chvatal A, and Sykova E. Glutamate-, kainate- and NMDA-evoked membrane currents in identified glial cells in rat spinal cord slice. Physiol Res 47: 365-375, 1998.